Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
Phase 2
Not yet recruiting
- Conditions
- Thyroid Cancer
- Interventions
- Drug: Iodine-124Procedure: Positron Emission Tomography (PET)/Computerized tomography (CT)
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 58
- Registration Number
- NCT06961084
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Recruiting
- Conditions
- Intracranial Neoplasm
- Interventions
- Drug: Fluorethyltyrosine (18-F)Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 199
- Registration Number
- NCT06474533
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
Phase 1
Completed
- Conditions
- Liver FibrosisPulmonary FibrosisMyocardial Fibrosis
- Interventions
- Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 16
- Registration Number
- NCT05180162
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
Phase 3
Recruiting
- Conditions
- Hyperparathyroidism, Primary
- Interventions
- Procedure: Positron emission tomography (PET)
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 140
- Registration Number
- NCT04895631
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
Phase 2
Active, not recruiting
- Conditions
- Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8
- Interventions
- Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 15
- Registration Number
- NCT04716725
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
Imaging of Solid Tumors Using FAP-2286
Phase 1
Recruiting
- Conditions
- Metastatic CancerSolid Tumors, Adult
- Interventions
- Procedure: Positron Emission Tomography (PET) imagingDrug: Gallium-68 labelled (68Ga-) FAP-2286Drug: Copper-64 labeled (64Cu-) FAP-2286
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 131
- Registration Number
- NCT04621435
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
Phase 2
Completed
- Conditions
- Low Grade GliomaRecurrent WHO Grade III GliomaRecurrent GlioblastomaRecurrent World Health Organization (WHO) Grade II GliomaIntracranial Neoplasm
- Interventions
- Drug: F-18 Fluoroethyltyrosine (FET)Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2019-08-05
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 143
- Registration Number
- NCT04044937
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
Phase 3
Completed
- Conditions
- Prostate Cancer
- Interventions
- Drug: Ga-68 labeled PSMA-11Device: Positron emission tomography-computed tomography (PET/CT)Device: Positron emission tomography-magnetic resonance imaging (PET/MRI)
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 485
- Registration Number
- NCT03803475
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
18F-Fluorocholine for the Detection of Parathyroid Adenomas
Phase 2
Completed
- Conditions
- Hyperparathyroidism, Primary
- Interventions
- Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2018-12-04
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 98
- Registration Number
- NCT03764007
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence
Phase 3
Completed
- Conditions
- Prostate Cancer
- Interventions
- Drug: Ga-68 labeled PSMA-11 PET
- First Posted Date
- 2017-11-27
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 346
- Registration Number
- NCT03353740
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath